Pain on Injection of Propofol: a Comparison of Lidocaine and Alkalinized Lidocaine

Sponsor
Inonu University (Other)
Overall Status
Completed
CT.gov ID
NCT01773044
Collaborator
(none)
300
1
2
2
149.7

Study Details

Study Description

Brief Summary

Aim: The aim of this study was to compare the efficacy of pretreatment 0.5 mg/kg lidocaine and 0.5 mg/kg alkalinized lidocaine for prevention of propofol induced pain.

Methods: In this double-blind, placebo controlled study, 300 adults patients ASA I or II, scheduled to undergo elective surgery, were randomly assigned into three groups of 100 each. Group L, recevied 0.05 mL/kg lidocaine (% 2 lidocaine 5 mL + 5 mL SF), Group A, 0.05 mL/kg lidocaine with bicarbonate ( % 2 lidocaine 5 mL + 1 mL %8,4 NaHCO3+ 4 mL SF) and control group received isotonic saline pretreatment in the dorsum of the hand, followed by propofol 30 sec later. A blinded researcher assessed the patient's pain level via a four-point scale.

Condition or Disease Intervention/Treatment Phase
  • Drug: alkalinized lidocaine
  • Drug: Lidocaine
  • Drug: Placebo (for alcalinized lidocaine)
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Study Start Date :
Sep 1, 2012
Actual Primary Completion Date :
Nov 1, 2012
Actual Study Completion Date :
Nov 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: alkalinized lidocaine & lidocaine

Drug: alkalinized lidocaine
recevied 0.05 mL/kg lidocaine with bicarbonate ( % 2 lidocaine 5 mL + 1 mL %8,4 NaHCO3+ 4 mL SF)

Drug: Lidocaine
0.05 mL/kg lidocaine (% 2 lidocaine 5 mL + 5 mL SF),

Active Comparator: alkalinized lidocaine &Placebo

Drug: alkalinized lidocaine
recevied 0.05 mL/kg lidocaine with bicarbonate ( % 2 lidocaine 5 mL + 1 mL %8,4 NaHCO3+ 4 mL SF)

Drug: Placebo (for alcalinized lidocaine)

Outcome Measures

Primary Outcome Measures

  1. Pain on injection of propofol [5 th minutes after propofol injection]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • undergoing elective surgery
Exclusion Criteria:
  • allergy to the study drug

Contacts and Locations

Locations

Site City State Country Postal Code
1 Inonu university medicine faculty Malatya Turkey 44280

Sponsors and Collaborators

  • Inonu University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ülkü Özgül, department of anesthesiology, Inonu University
ClinicalTrials.gov Identifier:
NCT01773044
Other Study ID Numbers:
  • ulkü_1
First Posted:
Jan 23, 2013
Last Update Posted:
Jan 23, 2013
Last Verified:
Jan 1, 2013
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 23, 2013